Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Sanofi
Engages in the research, production and distribution of pharmaceutical products

Sanofi engages in the research, production and distribution of pharmaceutical products.

It operates through the following business segments: Pharmaceuticals, Human Vaccines, and Animal Health.

The Pharmaceuticals segment includes research, development, production and sales activities relating to pharmaceutical products, including prescription, consumer health care, and generic products.

This segment also includes equity affiliates and joint ventures with pharmaceutical business activities.

The Human Vaccines segment includes research, development, production and marketing of vaccines.

The Animal Health segment comprises the research, development, production and marketing activities for Merial, which offers a range of medicines and vaccines for animal species.

The company was founded on April 28, 1994 and is headquartered in Paris, France.

Number of employees : 106 859 persons.
Sales per Businesses
20152016Delta
EUR (in Million)%EUR (in Million)%
Pharmaceuticals29,79986.3%29,24486.5% -1.86%
Vaccines4,74313.7%4,57713.5% -3.5%
Sales per Regions
20152016Delta
EUR (in Million)%EUR (in Million)%
United States12,24635.5%12,39136.6% +1.18%
Western Europe5,24815.2%---
Asia (Excluding Pacific Region)3,53610.2%---
Latin America3,0478.8%2,5037.4% -17.85%
Eastern Europe and Turkey2,3666.8%---
France2,2486.5%2,2066.5% -1.87%
Africa and Middle-East2,2226.4%---
Japan2,0345.9%1,6885% -17.01%
Other834.002.4%699.002.1% -16.19%
Rest of the World761.002.2%898.002.7% +18%
Europe--6,47319.1%-
Asia (Excluding South Asia)--3,1099.2%-
Africa, Middle East and South Asia--2,7648.2%-
Eurasia--1,0903.2%-
Managers
NameAgeSinceTitle
Olivier Brandicourt MD, PhD612015Chief Executive Officer & Director
Serge Weinberg662009Chairman
Jérôme Contamine602009Chief Financial Officer & EVP-Finance
Elias A. Zerhouni, MD662011President-Global Research & Development
Yong-Jun Liu MD, PhD-2016Head-Global Research & Development
Ameet Nathwani MD, MBA502016Executive Vice President-Medical Affairs
Robert Castaigne, PhD712000Independent Director
Claudie Haigneré MD, PhD602008Independent Director
Carole Piwnica592010Independent Director
Suet-Fern Lee592011Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 1,260,754,026 1,120,803,929 88.9% 5,000,000 0.4% 88.9%
Shareholders
NameEquities%
L'Oréal SA 118,227,307 9.38%
Dodge & Cox 28,501,352 2.26%
The Vanguard Group, Inc. 25,922,523 2.06%
Norges Bank Investment Management 25,853,367 2.05%
Plan d'Epargne Entreprise Sanofi Synthelabo 18,421,747 1.46%
Amundi Asset Management SA (Investment Management) 16,591,411 1.32%
BlackRock Fund Advisors 16,391,800 1.30%
Lyxor International Asset Management SAS 13,520,431 1.07%
Natixis Asset Management SA 11,497,992 0.91%
BlackRock Advisors (UK) Ltd. 9,132,684 0.72%
Holdings
NameEquities%Valuation
Regeneron Pharmaceuticals (REGN) 23,641,74422.6%11,622,754,185 USD
Aventis Pharma Limited (AVPH) 13,909,58760.4%930,157,034 USD
Alnylam Pharmaceuticals, Inc. (ALNY) 10,554,13411.5%873,249,047 USD
Sanofi (SAN) 2,115,4660.17%201,326,530 USD
Zentiva SA (ROSCD) 312,341,64974.9%181,882,789 USD
Myokardia Inc (MYOK) 4,018,89912.8%62,493,879 USD
JHL Biotech Inc (6540) 28,415,11112.9%59,125,311 USD
Regulus Therapeutics Inc (RGLS) 5,053,7794.87%5,306,468 USD
SCYNEXIS Inc (SCYX) 1,677,0576.50%2,884,538 USD
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
SANOFI6.97%122 127
JOHNSON & JOHNSON15.12%355 979
NOVARTIS7.69%216 915
ROCHE HOLDING LTD.3.78%216 699
PFIZER0.59%194 554
MERCK AND COMPANY4.45%167 705
BAYER8.85%104 602
GLAXOSMITHKLINE-4.61%94 281
BRISTOL-MYERS SQUIBB COMPANY-3.46%92 525
NOVO NORDISK A/S12.45%88 994
ELI LILLY AND COMPANY4.79%84 853
ABBOTT LABORATORIES26.89%84 683
ALLERGAN PLC6.66%74 881
ASTRAZENECA0.21%72 406
SHIRE-19.63%43 974
TAKEDA PHARMACEUTICAL CO LTD21.76%42 619
ASTELLAS PHARMA INC-15.07%26 156
JIANGSU HENGRUI MEDICINE CO., LTD18.04%22 683
CHUGAI PHARMACEUTICAL CO LTD28.02%22 007
SHIONOGI & CO LTD1.73%17 154
MYLAN NV-19.48%16 475
Connections : Sanofi
Académie des Technologies
Piasa Holding SAS
Madrigall SA
Council on Foreign Relations, Inc.
Fondation C.Génial
Sanofi-Aventis Europe SAS
Naxos UK Ltd.
Sanofi-Aventis Participations SA
Rickmers Trust Management Pte Ltd.
Total Upstream UK Ltd.
Fondation pour l’Université de Lyon
Sanofi-Aventis U.S. LLC
Academie de l'air et de l'espace
National Committee on United States-China Relations, Inc.
Financière Piasa SAS
Sanofi Pasteur Holding SA
Maremma SASU
Sanofi Pasteur Holding Ltd.
Weinberg Capital Partners SAS
Total Gestion Filiales
Omnium Insurance & Reinsurance Co. Ltd.
Research!America
Fondation Lacoste
King Abdullah University of Science & Technology
L'Oréal Corporate Foundation
Warp Drive Bio LLC
Academie des Sports
Piasa SA
Académie des Sciences et Technologies
Big Red, Inc.
i2O Water Ltd.
NAXOS Capital Managers SARL
Elevance Renewable Sciences, Inc.
Académie Nationale de Médecine
National Academy of Engineering
Select Music & Video Distribution Ltd.
Institute of Medicine
New York State Bar Association
The Johns Hopkins University
Morgan Lewis Stamford LLC
AXA Group Solutions
World Justice Project
Nanyang Technological University
International Federation of Pharmaceutical Manufacturers A
Stamford Corporate Services Pte Ltd.
International Bar Association
AXA Asia SAS
Pharmaceutical Research & Manufacturers of America
Singapore Bar
The Children's Aid Society, Inc.
Singapore Academy of Law
Company contact information
54 rue la Boétie
FR-75008 Paris
France

Phone : +33 (0)1 53 77 40 00
Fax : +33 (0)1 53 77 44 63
Internet : http://www.sanofi.com
Markets and indexes
- PEA / SRD eligible : YES / YES
- Euronext Paris
- Compartiment A
- CAC 40 / CAC All Shares, CAC All-Tradable, CAC Large 60, Euronext 100, EuroStoxx 50, FTSE Eurotop 100, Low Carbon 100 Europe, PEA, Stoxx Europe 50, Stoxx France 50, Stoxx Global 200
Stock Exchange Codes
- ISIN Code :  FR0000120578
- Bloomberg Code :  SAN:FP
- Reuters Code :  SASY.PA
- Datastream Code :  F:SQ@F
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem